BNF:

6.1.2

Status:

Green

Decision Date:

March 2020

Comments

GREEN: reclassified from GREY, to be prescribed alongside other treatment options as per type 2 diabetes guidance. 

Healthcare professionals should be aware of warnings and precautions for use in at-risk patients – see MHRA drug safety update (August 2011)

 

 

search again